HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 579897Generated: October 30, 2026
4-Methylmorpholine → [N-(t-butyloxycarbonyl)statine]-glutamic acid dibenzyl ester
https://huagongshe.com/reaction/579897
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | 1-Cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate | HCID 17220 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | (3S,4S)-4-((tert-Butoxycarbonyl)amino)-3-hydroxy-6-methylheptanoic acid | HCID 2755962 | — |
| Reactant | L-Glutamic acid dibenzyl ester tosylate | HCID 13233366 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | [N-(t-butyloxycarbonyl)statine]-glutamic acid dibenzyl ester | HCID 86742211 | — |
Reaction Steps
N-hydroxybenzotriazole (324 mg., 2.4 mmoles), N-methyl-morpholine (202 mg., 2 mmoles), L-glutamic acid dibenzyl ester p-toluenesulfonate (995 mg., 2 mmoles), N-(t-butyloxycarbonyl)-statine (660 mg., 2.4 mmoles) and 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide metho p-toluene sulfonate (1271 mg., 80% pure, 2.4 mmoles) were sequentially dissolved in methylene chloride (100 ml.) at 0° C. and the resulting solution stirred for 19 hours at 20° C. The reaction mixture was then washed consecutively with 5.5% aqueous HCl, saturated aqueous NaHCO3 solution and brine, and dried over anhydrous MgSO4After filtration and evaporation, 1269 g. of crude [N-(t-butyloxycarbonyl)statine]-glutamic acid dibenzyl ester was obtained as an oil (lH NMR, CDCl3, 5.2 delta, 2H s [benzyl CH2 ]). This oil (1269 g.) was dissolved in 10 ml. of 3.7N HCl/dioxane and the resulting solution allowed to stand for one hour at room temperature. The solution was then evaporated under high vacuum to a residue, which was triturated in ether and dried with nitrogen to yield 900 mg. of statine-glutamic acid dibenzyl ester hydrochloride as a foam (lH NMR, CDCl3, 5.2 delta, 2H s [benzyl CH2 ]). N-hydroxybenzotriazole (186 mg., 1.38 mmoles), N-methyl-morpholine (116 mg., 1.15 mmoles), a quantity of the statine-glutamic acid dibenzyl ester hydrochloride foam formed above (600 mg., 1.15 mmoles), N-(t-butyloxycarbonyl)-L-alanine (261 mg., 1.38 mmoles) and 1-cyclohexyl-3-(2-morpholinoethyl)-carbodiimide metho p-toluene sulfonate (732 mg., 80% pure, 1.38 mmoles) were sequentially dissolved in methylene chloride (60 ml.) at 0° C. and the resulting solution stirred for 19 hours at 20° C. The reaction mixture was then washed consecutively with 5.5% aqueous HCl, saturated aqueous NaHCO3 solution and brine, and dried over anhydrous MgSO4After filtration and evaporation, 743 mg. of crude product was obtained as a foam (lH NMR, CDCl3, 5.2 delta, 2H s [benzyl CH2 ]).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04749687 |
|---|
| Source dataset | uspto-grants-1988_06 |
|---|
| ORD ID | ord-1d52262c139a446388cead6afa88aeba |
|---|
| Source note | uspto-grants-1988_06 |
|---|